DK2170906T3 - Fusionerede thiazolderivater som kinaseinhibitorer - Google Patents

Fusionerede thiazolderivater som kinaseinhibitorer

Info

Publication number
DK2170906T3
DK2170906T3 DK08775774.6T DK08775774T DK2170906T3 DK 2170906 T3 DK2170906 T3 DK 2170906T3 DK 08775774 T DK08775774 T DK 08775774T DK 2170906 T3 DK2170906 T3 DK 2170906T3
Authority
DK
Denmark
Prior art keywords
kinase inhibitors
thiazole derivatives
fused thiazole
substituted
derivatives
Prior art date
Application number
DK08775774.6T
Other languages
Danish (da)
English (en)
Inventor
Rikki Peter Alexander
Pavandeep Singh Aujla
Karen Viviane Lucile Crepy
Anne Marie Foley
Richard Jeremy Franklin
Original Assignee
Ucb Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0612644A external-priority patent/GB0612644D0/en
Priority claimed from GB0620062A external-priority patent/GB0620062D0/en
Application filed by Ucb Pharma Sa filed Critical Ucb Pharma Sa
Priority claimed from PCT/GB2008/002194 external-priority patent/WO2009001089A1/en
Application granted granted Critical
Publication of DK2170906T3 publication Critical patent/DK2170906T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK08775774.6T 2006-06-26 2008-06-24 Fusionerede thiazolderivater som kinaseinhibitorer DK2170906T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0612644A GB0612644D0 (en) 2006-06-26 2006-06-26 Therapeutic agents
GB0620062A GB0620062D0 (en) 2006-10-10 2006-10-10 Therapeutic agents
PCT/GB2007/002390 WO2008001076A1 (en) 2006-06-26 2007-06-26 Fused thiazole derivatives as kinase inhibitors
PCT/GB2008/002194 WO2009001089A1 (en) 2007-06-26 2008-06-24 Fused thiazole derivatives as kinase inhibitors

Publications (1)

Publication Number Publication Date
DK2170906T3 true DK2170906T3 (da) 2013-06-24

Family

ID=38671000

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08775774.6T DK2170906T3 (da) 2006-06-26 2008-06-24 Fusionerede thiazolderivater som kinaseinhibitorer

Country Status (20)

Country Link
US (3) US8242116B2 (OSRAM)
EP (2) EP2035436B1 (OSRAM)
CN (1) CN101687885B (OSRAM)
AT (1) ATE510840T1 (OSRAM)
AU (1) AU2008269577B2 (OSRAM)
CA (1) CA2692085C (OSRAM)
CO (1) CO6270229A2 (OSRAM)
CY (1) CY1114419T1 (OSRAM)
DK (1) DK2170906T3 (OSRAM)
EA (1) EA017187B1 (OSRAM)
ES (2) ES2365258T3 (OSRAM)
HR (1) HRP20130523T1 (OSRAM)
IL (1) IL202659A0 (OSRAM)
ME (1) ME01592B (OSRAM)
MX (1) MX2009013740A (OSRAM)
MY (1) MY148852A (OSRAM)
PL (1) PL2170906T3 (OSRAM)
PT (1) PT2170906E (OSRAM)
RS (1) RS52824B (OSRAM)
WO (1) WO2008001076A1 (OSRAM)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009071895A1 (en) * 2007-12-04 2009-06-11 Ucb Pharma S.A. Fused thiazole and thiophene derivatives as kinase inhibitors
WO2009071890A1 (en) * 2007-12-04 2009-06-11 Ucb Pharma S.A. Tricyclic kinase inhibitors
WO2009085185A1 (en) 2007-12-19 2009-07-09 Amgen Inc. Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
JP5530422B2 (ja) 2008-04-07 2014-06-25 アムジエン・インコーポレーテツド 細胞周期阻害薬としてのｇｅｍ−二置換およびスピロ環式アミノピリジン／ピリミジン
JPWO2009130900A1 (ja) * 2008-04-24 2011-08-11 日本曹達株式会社 オキシム誘導体、中間体化合物および植物病害防除剤
US8603945B2 (en) * 2008-07-23 2013-12-10 The Regents Of The University Of California Methods and compositions for providing salicyclic acid-independent pathogen resistance in plants
US20110172217A1 (en) * 2008-09-05 2011-07-14 Shionogi & Co., Ltd. Ring-fused morpholine derivative having pi3k-inhibiting activity
MX2011008645A (es) 2009-02-17 2011-09-30 Vertex Pharma Inhibidores de tetrahidrotiazolopiridina de fosfatidilinositol 3 cinasa.
JP2012520887A (ja) * 2009-03-18 2012-09-10 シェーリング コーポレイション ジアシルグリセロールアシルトランスフェラーゼの阻害剤としての二環式化合物
UY32582A (es) * 2009-04-28 2010-11-30 Amgen Inc Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamífero
ES2638323T3 (es) 2009-05-20 2017-10-19 Glaxosmithkline Llc Derivados de tiazolopirimidinona como inhibidores de PI3 quinasa
GB0912946D0 (en) 2009-07-24 2009-09-02 Addex Pharmaceuticals Sa New compounds 5
US9200007B2 (en) 2009-08-20 2015-12-01 Karus Therapeutics Limited Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
EA019980B1 (ru) 2009-12-18 2014-07-30 Янссен Фармацевтика Нв БИЦИКЛИЧЕСКИЕ ТИАЗОЛЫ В КАЧЕСТВЕ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR5
BR112012014235A2 (pt) * 2009-12-18 2016-06-14 Janssen Pharmaceutica Nv tiazóis bicíclicos como moduladores alostéricos de receptores mglur5
ES2575566T3 (es) 2010-06-15 2016-06-29 Bayer Intellectual Property Gmbh Nuevos derivados de arilamida orto-sustituidos
BR112013007056A2 (pt) 2010-10-01 2019-09-24 Basf Se compostos de imina
MX2013004003A (es) * 2010-10-13 2013-10-01 Millenium Pharmaceuticals Inc Heteroarilos y usos de los mismos.
US20140018347A1 (en) * 2010-11-24 2014-01-16 Exelixis, Inc. BENZOXAZEPINES AS INHIBITORS OF mTOR AND METHODS OF THEIR USE AND MANUFACTURE
CN102649777B (zh) * 2011-02-25 2014-03-12 中国中化股份有限公司 一种制备1-芳基-3-羧基-5-吡唑啉酮类化合物的方法
WO2012129344A1 (en) 2011-03-23 2012-09-27 Amgen Inc. Fused tricyclic dual inhibitors of cdk 4/6 and flt3
WO2013093849A1 (en) 2011-12-22 2013-06-27 Novartis Ag Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
KR102028793B1 (ko) 2013-03-14 2019-10-07 에피자임, 인코포레이티드 아르기닌 메틸기 전이효소 억제제 및 이의 용도
US9120757B2 (en) 2013-03-14 2015-09-01 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
US8952026B2 (en) 2013-03-14 2015-02-10 Epizyme, Inc. PRMT1 inhibitors and uses thereof
EP2970181B1 (en) 2013-03-14 2017-06-07 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
US9394258B2 (en) 2013-03-14 2016-07-19 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
WO2014153172A1 (en) 2013-03-14 2014-09-25 Epizyme, Inc. Pyrazole derivatives as prmt1 inhibitors and uses thereof
US9023883B2 (en) 2013-03-14 2015-05-05 Epizyme, Inc. PRMT1 inhibitors and uses thereof
US9133189B2 (en) 2013-03-14 2015-09-15 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
US20160031839A1 (en) 2013-03-14 2016-02-04 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
US9776972B2 (en) 2013-03-14 2017-10-03 Epizyme Inc. Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof
EP3060548B1 (de) * 2013-10-21 2018-10-10 Umicore AG & Co. KG Monoarylierung aromatischer amine
GB201402431D0 (en) 2014-02-12 2014-03-26 Karus Therapeutics Ltd Compounds
GB201514758D0 (en) 2015-08-19 2015-09-30 Karus Therapeutics Ltd Formulation
GB201514760D0 (en) 2015-08-19 2015-09-30 Karus Therapeutics Ltd Compounds and method of use
GB201514754D0 (en) * 2015-08-19 2015-09-30 Karus Therapeutics Ltd Compounds
WO2017156350A1 (en) 2016-03-09 2017-09-14 K-Gen, Inc. Methods of cancer treatment
CN108570043A (zh) * 2018-06-20 2018-09-25 王延娇 一种化合物及其作为选择性pi3k抑制剂在治疗肿瘤中的应用
US20220202824A1 (en) 2018-09-13 2022-06-30 Stemline Therapeutics, Inc. Methods for Treating Centronuclear Myopathy
BR112021010453A2 (pt) 2018-12-19 2021-08-24 Leo Pharma A/S Composto, e, composição farmacêutica
AU2020207089B2 (en) * 2019-01-08 2025-08-14 Kyorin Pharmaceutical Co., Ltd. 15-PGDH inhibitor
WO2020160151A1 (en) 2019-01-31 2020-08-06 Kyorin Pharmaceutical Co., Ltd. 15-pgdh inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0508471D0 (en) 2005-04-26 2005-06-01 Celltech R&D Ltd Therapeutic agents

Also Published As

Publication number Publication date
RS52824B (OSRAM) 2013-10-31
ATE510840T1 (de) 2011-06-15
CN101687885B (zh) 2012-08-22
EA201000038A1 (ru) 2010-06-30
CA2692085C (en) 2015-10-13
EP2170906A1 (en) 2010-04-07
US20130079330A1 (en) 2013-03-28
MX2009013740A (es) 2010-02-01
US8242116B2 (en) 2012-08-14
ES2365258T3 (es) 2011-09-27
CN101687885A (zh) 2010-03-31
HRP20130523T1 (en) 2013-07-31
EP2035436B1 (en) 2011-05-25
ME01592B (me) 2014-09-20
AU2008269577A1 (en) 2008-12-31
PL2170906T3 (pl) 2013-08-30
IL202659A0 (en) 2010-06-30
US8338592B2 (en) 2012-12-25
PT2170906E (pt) 2013-06-25
US20110003785A1 (en) 2011-01-06
AU2008269577B2 (en) 2012-12-20
EP2035436A1 (en) 2009-03-18
US8710054B2 (en) 2014-04-29
EA017187B1 (ru) 2012-10-30
CA2692085A1 (en) 2008-12-31
MY148852A (en) 2013-06-14
CO6270229A2 (es) 2011-04-20
WO2008001076A1 (en) 2008-01-03
US20100137302A1 (en) 2010-06-03
ES2416364T3 (es) 2013-07-31
CY1114419T1 (el) 2016-08-31
EP2170906B1 (en) 2013-04-03

Similar Documents

Publication Publication Date Title
DK2170906T3 (da) Fusionerede thiazolderivater som kinaseinhibitorer
ATE526021T1 (de) Kondensierte thiazol-derivate als kinase-hemmer
NO20083739L (no) Tieno-pyridinderivater som MEK-inhibitorer
WO2009081105A3 (en) Quinoxaline and quinoline derivatives as kinase inhibitors
WO2008020206A3 (en) Fused thiophene derivatives as mek inhibitors
SMT201600089B (it) Composti di 3,4-diidropirazino[2,3-b]pirazin-2(1 h)-one come inibitori di chinasi mtor per indicazioni oncologiche e malattie associate al percorso mtor/p13k/akt
NO20081133L (no) Tieno[2,3-B]-pyridin-5-karbonitriler som protein kinase inhibitorer
DK3880676T3 (da) 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-on-derivater som hpk1-inhibitorer til behandling af cancer
EP3542629A3 (en) Dithiol compounds, derivatives, and uses therefor
MX2009012595A (es) Derivados de espiroindolinona.
IL287521B2 (en) History of 3-amino-h4-benzo[e][4,2,1]thiadiazine 1,1-dioxide as MRGX2 inhibitors
CL2008003280A1 (es) Compuestos derivados de 1h-pirazolo[3,4-b]piridina)-4-aril sustituidas; la composicion farmaceutica que los contiene; y sus procesos de preparacion.
CO6220934A2 (es) Derivados de imidazolidinacaboxamida como inhibidores de lipasas y foffolipasas
WO2006098961A3 (en) Fused thieno [2, 3-b] pyridine and thiazolo [5, 4-b] pyridine compounds for inhibiting ksp kinesin activity
CR20120585A (es) Una forma cristalina de (r)-7cloro-n-(quinuclidin-3-il) benzo [b] tiofeno-2-carboxamida monohidrato
NO20091817L (no) Kinase inhibitorer
UA99469C2 (ru) Конденсированные производные тиазола как ингибиторы киназы
IL280122A (en) Imidazo[2,1-B]pyridazine derivatives as TRK inhibitors
EP3851439A4 (en) Furo[3,4-b]pyrrole-containing btk inhibitor
PL3816164T3 (pl) Związek izotiazolo[5,4-d]pirymidynowy jako inhibitor irak4
EP2490693A4 (en) Pyrazolo [3,4-B] PYRIDINE-4-ON-KINASE INHIBITORS
DOP2009000289A (es) Derivados de tiazol fusionados como inhibidores de quinasa
NO20090269L (no) Fenolpentadienoylderivater og deres anvendelse som PAR-1-antagonister
DK2038288T3 (da) 4-amino-3-(azolylphenoxymethyl)thieno[3,2]pyridin-7-carboxylsyrederivater
DK1784403T3 (da) Pyrrolo[3,2-b]pyridinderivater samt fremgangsmåder til deres fremstilling